Preventing recurrent rheumatic fever: The role of register based programmes

Heart

Volumn 91, Issue 9, 2005, Pages 1131-1133

  McDonald, Malcolm ^a   Brown, A ^a   Noonan, S ^b   Carapetis, J R ^c  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

COMPUTER PROGRAM; COST BENEFIT ANALYSIS; DATA BASE; EDITORIAL; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RHEUMATIC FEVER; WORLD HEALTH ORGANIZATION;

AUSTRALIA; HUMANS; INFORMED CONSENT; RECURRENCE; REGISTRIES; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE;

EID: 23944521781     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.057570     Document Type: Editorial

References (16)

1. World Health Organization. Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting. Bull World Health Organ 1995;73:583-7.
2. Quinn R. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever. Rev Infect Dis 1989;11:928-53.
3. Tompkins D, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation 1972;45:543-51.
4. Toronto A, Fielder J, Frank C, et al. Prevention of rheumatic fever and rheumatic heart disease. Circulation 1970;61:A1-15.
5. Kaplan EL. Current status of rheumatic fever control programs in the United States. Public Health Rep 1981;96:267-8.
6. Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ 1981;59:285-94.
7. World Health Organization. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from phase 1 (1986-90). Bull World Health Organ 1992;7:213-18.
8. World Health Organization. The WHO global programme for the prevention of rheumatic fever and rheumatic heart disease: report of a consultation to review progress and develop future activities. Geneva: WHO, 2000:1-49.
9. Thornley C, McNicholas A, Baker M, et al. Rheumatic fever registers in New Zealand. NZ Pub Health Rep 2001;8(6):41-4.
10. Kumar R, Raizada A, Aggarwal AK, et al. A community-based rheumatic fever/rheumatic heart disease cohort: twelve-year experience. Indian Heart J 2002;54:54-8.
11. World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation. Geneva: WHO, 2004.
12. Noonan S, Edmond K, Krause V, et al. The top end rheumatic heart disease control program I. Report on progress. NT Dis Controll Bull 2001;8:15-18.
13. Brown A, Purton L, Schaeffer G, et al. Central Australian rheumatic heart disease control program: a report to the Commonwealth, November 2002. NT Dis Control Bull 2003;10:1-8.
14. Solomon DJ, Henry RC, Hogan JG, et al. Evaluation and implementation of public health registries. Public Health Rep 1991;106:142-50.
15. Rice MJ, Kaplan EL. Rheumatic fever in Minnesota. II. Evaluation of hospitalized patients and utilization of a state rheumatic fever registry. Am J Public Health 1979;69:767-71.
16. Verity C, Nicoll A. Consent, confidentiality, and the threat to public health surveillance. BMJ 2002;324:1210-12.